Highlights
ASX: MEB       MEDIBIO LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.02   +0.008 (66.67%)  0.014 - 0.029  96,258,387

Overview

 
Avg Volume (4 weeks):9,425,655
4 Weeks Range:0.008 - 0.032
4 Weeks Price Volatility (%):
50.00%
52 Weeks Range:0.008 - 0.24
52 Weeks Price Volatility (%):
5.17%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

BioProspect Limited is an Australia-based company, focused on the validation and commercialization of its exciting new heart rate variability technology acquired via the acquisition of Invatec Health. Invatec Health is a developer of medical diagnostic technology based on heart rate variability to enable diagnosis of mental health disorders including depression. After a decade of research and development, Invatec has created the quantitative test for depression and other mental illnesses. In addition, the Company has some legacy assets in the human health, personal care, animal health and nutrition and agricultural sectors. The Company's projects are Invatec Health, Frontier, Agripro and Regen. It also holds an investment in Frontier Oil Corporation, a Philippines-based oil and gas explorer.

  Be the first to like this.
 


 

742  456  689  9268 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MEB 0.02+0.008 
 BLK 0.013+0.001 
 PCL 0.002+0.001 
 EXO 0.0020.00 
 SPX 0.032+0.003 
 PMY 0.009+0.001 
 IBX 0.05-0.001 
 S32 3.01+0.03 
 AB1 0.1650.00 
 NOROA 0.0010.00 
Partners & Brokers